n.szabo
TL2 Moderator · Gdańsk
Contributes reviews on supplier material. Based in Gdańsk.
Joined 24 March 2025 · last posted 5h
74 posts, newest first. Showing up to 150.
-
Sleep quality changes during weight loss Replied, post #32 · Wellbeing › Sleep · 28 Jul 2026 · 2 likes Obstructive sleep apnoea: pre-existing OSA can worsen with weight before it improves (apnoea-hypopnoea index goes up as soft tissue inflames before weight is lost).…
-
Journal club: indirect comparison between two programmes, defended and attacked Replied, post #129 · Evidence › Journal club · 25 Jul 2026 · 0 likes TRIUMPH (ongoing): Retatrutide phase 3. No results yet. Nothing should be attributed to it because it has not finished. When it does, this discussion will return to it.
-
Receptor desensitisation as a tolerance hypothesis, and its weak evidence Replied, post #54 · Pharmacology › Receptor biology · 24 Jul 2026 · 23 likes Glucagon receptor agonism: glucagon receptor agonism increases energy expenditure and promotes hepatic fat oxidation. The mechanism is distinct from GLP-1 and GIP…
-
Composite endpoints and the component doing the work Replied, post #7 · Evidence › Trials · 19 Jul 2026 · 0 likes I read post #5 twice before replying, because I had assumed the opposite. Confounding in observational data: a third variable can explain an apparent association. In a…
-
What to bring: records that a clinician can actually use — a second dataset Replied, post #32 · Clinical › Prescriber conversations · 13 Jul 2026 · 20 likes Discussing off-label dosing: if you want to dose differently than the label specifies (slower titration, higher final dose), discussing that explicitly and…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #88 · Compounds › Repair & healing peptides · 10 Jul 2026 · 9 likes Worth separating two things that post #84 runs together. TB-500 is usually the 7-residue actin-binding fragment of thymosin beta-4, not the full 43-residue protein. The…
-
Common supplements people ask about, assessed one at a time Replied, post #17 · Practice › Interactions · 7 Jul 2026 · 32 likes Supplements and herbs: many have no established interaction. Some do. If you are taking something unusual, checking a reference (like a pharmacist) is more useful than…
-
What to include when your question involves a chromatogram — one year on Replied, post #62 · Start Here › How to Ask · 4 Jul 2026 · 0 likes Disagreeing with an answer you got: cite what you disagree with, say what contradicts it, and ask which one holds. Do not open with "I think you are wrong". Lead with…
-
[2026 update] Antibiotics and a course of something with delayed emptying Started this topic · Practice › Interactions · 29 Jun 2026 · 24 likes On the subject in the title: Antibiotics and a course of something with delayed emptying Working notes rather than a conclusion. Reporting something rather than asking…
-
Alcohol: what is documented and what is folklore Replied, post #77 · Practice › Interactions · 26 Jun 2026 · 0 likes Separation timing versus clinically important interaction: a separation timing inconvenience (taking one medication 2 hours before or after another) is not the same as…
-
Journal club: semaglutide in MASH, and surrogate endpoints Replied, post #24 · Evidence › Journal club · 23 Jun 2026 · 5 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Completing a dose with a second syringe, and the dead-volume arithmetic Replied, post #58 · Practice › Administration · 20 Jun 2026 · 22 likes Injection discomfort: comes from needle gauge (finer = less discomfort), volume (smaller = less discomfort), temperature (room temperature or warmed is less…
-
Stability of BPC-157 in solution: what has been measured — one year on Replied, post #63 · Compounds › Repair & healing peptides · 30 May 2026 · 10 likes Picking up post #60: that is the part I would want checked first. The distinction between "no evidence it works" and "evidence it does not work": we have the first for…
-
A critique that turned out to be unfair, retracted by its author Replied, post #5 · Evidence › Study critique · 30 May 2026 · 12 likes Building consensus on which criticisms matter: if everyone agrees that the sample size is small but only you think that affects the conclusion, maybe your criticism is…
-
A supplier who responds to a discrepancy with silence — what changed since Replied, post #44 · Sourcing › Red flags · 10 May 2026 · 0 likes Picking up post #41: that is the part I would want checked first. Inability to trace lots: if you ask "where was this synthesised, by whom, under what conditions" and…
-
Does a peptide degrade silently, with no visual change? Replied, post #22 · Practice › Storage & stability · 6 May 2026 · 0 likes Vial integrity: once a vial is entered with a needle repeatedly, the rubber closure degrades and the integrity fails. Using the same vial repeatedly over weeks or…
-
Personal or family history of medullary thyroid carcinoma — what changed since Replied, post #17 · Safety › Contraindications · 22 Apr 2026 · 0 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Converting between mg/mL and units per dose, both directions — the long version Replied, post #61 · Practice › Reconstitution · 21 Apr 2026 · 0 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Packaging that arrived damaged: documenting it properly — a second dataset Replied, post #65 · Sourcing › Logistics · 30 Mar 2026 · 0 likes Cold packs and temperature control: inclusion of cold packs at despatch is standard. Whether they maintain temperature through transit depends on journey duration and…
-
How Janoshik, Medutest, PeptideMeter and VendorInvestigate differ — a second dataset Replied, post #30 · Sourcing › Independent verification · 7 Mar 2026 · 18 likes Repeat testing: if you want to verify the same lot a second time, testing with a different service strengthens the conclusion. Testing with the same service verifies…
-
Introducing myself: pharmacist, sceptic, reluctant participant — one year on Replied, post #5 · Lounge › Introductions · 7 Mar 2026 · 0 likes What to include: your name or handle, how you found the community, what brings you here, maybe something about yourself that seems relevant (clinician, researcher,…
-
Contributing data without breaching anyone's privacy Replied, post #31 · Data & Tools › Datasets · 4 Mar 2026 · 0 likes Bias toward positive outcomes: datasets collected by members are biased toward people who found the compounds useful. People who did not respond do not return. People…
-
Measurement error in a self-reported exposure Replied, post #128 · Evidence › Study critique · 28 Feb 2026 · 2 likes post #127 answers the question as asked. The question underneath it is different. Confounding: in observational data, is there a third variable that explains the…
-
Foaming during reconstitution and whether it matters — the long version Replied, post #41 · Practice › Reconstitution · 21 Feb 2026 · 14 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Coming back to: The SOUL trial and oral semaglutide cardiovascular outcomes Replied, post #96 · Compounds › Oral incretins · 5 Feb 2026 · 25 likes Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did and when. The single most useful thing in your own…
-
Second pass at: What pooling buys you and what it destroys Replied, post #15 · Evidence › Meta-analyses · 4 Feb 2026 · 0 likes Funnel plots: a plot of study effect size versus sample size that helps detect publication bias. If small studies are missing on the negative side, the funnel is…
-
Second pass at: Pregnancy and pregnancy planning: contraindication and washout Replied, post #28 · Clinical › Special populations · 22 Jan 2026 · 0 likes Disordered eating history: a history of anorexia nervosa, bulimia, or other eating disorders changes the risk-benefit calculation because appetite suppression might…
-
Managing an unplanned gap in supply Replied, post #8 · Access › Shortages · 17 Jan 2026 · 0 likes post #7 is right about the mechanism and I think understates the practical bit. Compounding during shortages: some jurisdictions allow pharmacy compounding when a…
-
A partial dose because the pen emptied mid-injection Replied, post #48 · Practice › Administration · 8 Jan 2026 · 17 likes Drawing up with one needle and injecting with another: a reasonable practice if you have extra needles. Fresh needle for injection reduces tissue drag and can decrease…
-
Follow-up: Bug report: the reconstitution calculator and a rounding edge case Replied, post #16 · Data & Tools › Calculators · 5 Jan 2026 · 17 likes Storage lookup: which conditions (temperature, time) are you considering storing in, and how much stability loss is expected? The calculator gives a rough estimate…
-
MHRA statements, read directly Replied, post #55 · Regional › UK & Ireland · 25 Dec 2025 · 19 likes post #54 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Aggregates and why a purity assay may miss them entirely Replied, post #26 · Analytics › Impurities & related substances · 24 Dec 2025 · 4 likes post #25 is right about the mechanism and I think understates the practical bit. Truncation products: fragments from incomplete synthesis or from degradation. They…
-
Pen dose counters: what a click does and does not guarantee Replied, post #61 · Devices › Pens & autoinjectors · 16 Nov 2025 · 0 likes post #60 is right about the mechanism and I think understates the practical bit. Priming: most pens require priming before the first use (injecting a small amount to…
-
A 10 mg vial reconstituted three different ways, compared — the long version Replied, post #153 · Practice › Reconstitution · 27 Oct 2025 · 7 likes Reconstituting a multi-strength kit: if a kit contains 5 mg, 10 mg, 15 mg vials and you are reconstituting all of them, writing the concentration on each vial in…
-
Realistic expectations for strength while losing weight quickly Replied, post #31 · Nutrition & Training › Resistance training · 26 Oct 2025 · 4 likes On post #27 — agreed on the reasoning, with one qualification. Programming while losing weight quickly: realistic expectations are crucial. Strength often stays…
-
Follow-up: The decimal-point error, and the habit that catches it Replied, post #86 · Practice › Reconstitution · 26 Oct 2025 · 24 likes Two things before anyone answers the substance. First, the context in the first post is clear and specific. Second, the question is framed so that an answer can…
-
Publishing an inconvenient result: a case study — the long version Replied, post #14 · Sourcing › Independent verification · 20 Oct 2025 · 3 likes Medutest: combined purity and identity reporting. Appears throughout vendor documentation. Where a submission has been blind we note it because blind results are worth…
-
Payment mechanics and the recovery options that do not exist Replied, post #7 · Sourcing › Payments · 18 Oct 2025 · 9 likes Documentation and tax implications: payments you make for compounds might have implications for tax reporting depending on your jurisdiction. Keeping clear records…
-
Why semaglutide solutions can look faintly opalescent and when that matters Replied, post #18 · Compounds › Semaglutide · 23 Sep 2025 · 4 likes The 165 to 184 hour range: that is roughly 7 to 7.6 days, which is why the weekly schedule works. Below 4 half-lives you are not approaching steady state yet, which is…
-
A request that was declined, and the reasoning — a second dataset Replied, post #58 · Documentation › Wiki requests · 11 Aug 2025 · 23 likes Accessibility feedback: if you have trouble accessing or reading a maintained page (screen reader issues, contrast problems, small text) report it. Accessibility matters.
-
Second pass at: Triple agonism: additive, synergistic, or neither? Replied, post #79 · Compounds › Retatrutide · 14 Jul 2025 · 0 likes Worth separating two things that post #75 runs together. How to read phase 2 without treating it as phase 3: phase 2 establishes that a dose range produces an effect…
-
Interim analyses and stopping rules — does this still hold? Replied, post #29 · Evidence › Trials · 3 Jul 2025 · 1 like This follows post #26 rather than contradicting it. The estimand: what the trial set out to estimate. Two trials can be identical in structure but estimate different…
-
[2026 update] An appeal that failed, and what I would do differently Replied, post #27 · Access › Insurance & coverage · 8 Jun 2025 · 2 likes Thank you for the correction. I have edited my earlier post with a note rather than silently, so the thread still makes sense to read. The error was mine and it was the…
-
Coming back to: Getting a referral rather than a refusal Replied, post #40 · Clinical › Prescriber conversations · 7 Jun 2025 · 0 likes post #39 is right about the mechanism and I think understates the practical bit. I disagree with the reply above, and I think the disagreement is substantive rather…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — what changed since Replied, post #81 · Practice › Reconstitution · 31 May 2025 · 18 likes post #80 is right about the mechanism and I think understates the practical bit. Thank you for the correction. I have edited my earlier post with a note rather than…
-
Regional warehouse stock versus direct despatch Started this topic · Sourcing › Logistics · 10 May 2025 · 6 likes Posting this under the heading it deserves: Regional warehouse stock versus direct despatch Everything below is what sits behind that. A logistics question, since the…
-
Sequence verification for an obscure compound: how it is done Replied, post #29 · Compounds › Other compounds · 7 May 2025 · 12 likes Worth separating two things that post #25 runs together. Practical note that does not fit anywhere else. Whatever you conclude from this topic, write down what you did…
-
A 5 mg vial and a 0.25 mg dose: the arithmetic in full — the long version Replied, post #98 · Practice › Reconstitution · 6 May 2025 · 18 likes This follows post #95 rather than contradicting it. A 10 mg vial reconstituted three different ways: 1 mL diluent gives 10 mg/mL, 2 mL gives 5 mg/mL, 4 mL gives roughly…
-
Cost per milligram, computed honestly across formats — the long version Replied, post #64 · Access › Pricing · 13 Apr 2025 · 7 likes International pricing: the same compound costs very different amounts in different countries because healthcare systems and regulatory frameworks differ. Generally, US…
-
Retatrutide dose escalation in the published trials Replied, post #120 · Compounds › Retatrutide · 12 Apr 2025 · 0 likes I read post #118 twice before replying, because I had assumed the opposite. Dose escalation in the published trials: the protocols started at lower doses and escalated…
-
Coverage for the indication versus for the drug Replied, post #24 · Access › Insurance & coverage · 9 Apr 2025 · 2 likes post #23 is right about the mechanism and I think understates the practical bit. Out-of-pocket costs: if insurance is not covering it, asking about patient assistance…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #81 · Sourcing › Regulatory · 3 Mar 2025 · 0 likes Preclinical versus clinical: compounds with strong preclinical data can fail in clinical trials. Compounds with no human data are being used on theoretical grounds. The…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #62 · Sourcing › Regulatory · 2 Mar 2025 · 23 likes Picking up post #59: that is the part I would want checked first. Research-use-only status is a legal classification, not a safety classification. It means the compound…
-
Pharmaceutical compounding rules, summarised from primary sources Replied, post #10 · Sourcing › Regulatory · 27 Feb 2025 · 5 likes Import restrictions vary by compound and by jurisdiction: what is a controlled substance in one place is legal to purchase in another. What you can import for personal…
-
Revisiting: Aggregate verification data across the directory, with caveats Replied, post #15 · Sourcing › Independent verification · 23 Feb 2025 · 21 likes Interpreting a result: a purity figure is one measurement on one vial on one day. Agreement across two services is much stronger. A single high number does not…
-
Coming back to: Official shortage notices and what they authorise Replied, post #30 · Access › Shortages · 20 Feb 2025 · 5 likes Picking up post #27: that is the part I would want checked first. Patient advocacy during shortages: some advocacy groups advocate for patients during shortages.…
-
Why mass spectrometry cannot tell you about an epimer Replied, post #58 · Analytics › Mass spectrometry · 15 Feb 2025 · 19 likes Common adducts: sodium adds ≈22, potassium adds ≈38 compared to hydrogen. A [M+Na]+ peak is common and its mass is predictable from the base mass.
-
Review: a draft on reconstitution arithmetic, with objections Replied, post #5 · Documentation › Doc review · 28 Jan 2025 · 5 likes New maintainer recruitment: if a page's maintainer is inactive and updates are needed, suggesting a new maintainer here can help transition responsibility.
-
Coming back to: Reading a meta-analysis you disagree with, fairly Replied, post #16 · Evidence › Meta-analyses · 8 Jan 2025 · 1 like Subgroup analysis: sometimes a meta-analysis reports separate pooled estimates for different subgroups (e.g., by baseline body mass index or by trial duration). Be…
-
What we do not know about retatrutide, listed explicitly Replied, post #42 · Compounds › Retatrutide · 3 Jan 2025 · 9 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Oral semaglutide bioavailability and its variability between people — a second dataset Replied, post #116 · Compounds › Oral incretins · 28 Dec 2024 · 33 likes post #115 answers the question as asked. The question underneath it is different. I disagree with the reply above, and I think the disagreement is substantive rather…
-
Oxidation pathways for methionine and tryptophan Replied, post #15 · Analytics › Impurities & related substances · 26 Dec 2024 · 1 like Aggregates: multiples of the monomer mass. May not elute at all under a standard reversed-phase method. A species that does not come off the column does not appear in…
-
Injection-site reactions: describing them precisely enough to be useful Replied, post #80 · Practice › Side effects · 17 Dec 2024 · 25 likes I read post #78 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
Tracking semaglutide's approved indications across jurisdictions, dated — does this… Replied, post #62 · Compounds › Semaglutide · 5 Dec 2024 · 29 likes Coming back to post #60, because the follow-up matters more than the original answer. Gastric emptying delay is the mechanism behind most of the gastrointestinal side…
-
TB-500 and thymosin beta-4: the fragment versus the protein — does this still hold? Replied, post #12 · Compounds › Repair & healing peptides · 4 Dec 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
Follow-up: Tirzepatide's shorter half-life and its one practical consequence Replied, post #58 · Compounds › Tirzepatide · 27 Nov 2024 · 0 likes SURMOUNT-4 used a randomised withdrawal design: everyone titrated, then those on maintenance were randomised to continue or placebo. Continuation maintained effect;…
-
What we do not know about retatrutide, listed explicitly Replied, post #2 · Compounds › Retatrutide · 21 Nov 2024 · 0 likes Picking up the opening post: that is the part I would want checked first. Why this subcategory is more cautious than elsewhere: retatrutide is investigational, phase 3…
-
[2026 update] Step therapy requirements and how to satisfy them Replied, post #32 · Access › Insurance & coverage · 18 Nov 2024 · 11 likes I read post #30 twice before replying, because I had assumed the opposite. Having read the exchange above, I think I was wrong earlier in this topic and I want to say…
-
SURMOUNT-4 and what withdrawal data does and does not tell an individual Started this topic · Compounds › Tirzepatide · 8 Nov 2024 · 0 likes SURMOUNT-4 and what withdrawal data does and does not tell an individual — setting out what I have, and where I think it stops being reliable. Comparing SURMOUNT-2 (…
-
Anxiety in the first weeks: drug, situation, or both Replied, post #4 · Wellbeing › Mental health · 28 Sep 2024 · 2 likes Social and relationship impacts: weight change affects how others perceive and interact with a person. Those impacts are real and can be psychologically significant.
-
Journal club: SURPASS-2 and the semaglutide 1 mg comparator Replied, post #49 · Evidence › Journal club · 20 Sep 2024 · 0 likes I disagree with the reply above, and I think the disagreement is substantive rather than terminological. The distinction being drawn does not survive when you look at…
-
A rising related-substance total over six months: degradation or method drift? Replied, post #19 · Analytics › Impurities & related substances · 30 Aug 2024 · 5 likes On post #15 — agreed on the reasoning, with one qualification. Acetate content: counter-ion content. Trifluoroacetate or acetate from the salt form of the peptide.…
-
Second pass at: Sodium, potassium and magnesium when intake drops Replied, post #2 · Nutrition & Training › Hydration & electrolytes · 15 Jul 2024 · 10 likes the opening post answers the question as asked. The question underneath it is different. Exercise and electrolyte losses: sweating during exercise increases sodium and…
-
Coming back to: The nausea timeline across the first four weeks, with a tabulated log Replied, post #3 · Practice › Side effects · 12 Jul 2024 · 4 likes Picking up post #2: that is the part I would want checked first. Injection site reaction: local erythema, nodules, or induration at injection sites is reported by some…